Delivery Order SPE2DB20D2002-SPE2DB25FL38C
- Not listed
- The Defense Logistics Agency awarded a $14,113.92 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens valued at $5,094.18. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, issued on September 4, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $19,862.57 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical distributor for federal military and healthcare systems. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,843.65 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 16, 2025, with completion scheduled for September 17, 2025. This delivery order represents a firm fixed price procurement issued under a non-set-aside competitive acquisition. The award was placed to AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors valued at $4,081.35 under a firm fixed-price contract. The order was placed on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,116.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pens with a ceiling value of $4,081.35. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,394.53 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors on April 21, 2025, with completion expected by April 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's existing...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL38CDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,891.31 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under DLA's broader medical supply chain operations. The contract is classified as a child award, indicating it derives from a larger indefinite delivery vehicle. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order falls under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Mounjaro supply supports DLA's pharmaceutical procurement mission, which serves defense health requirements across multiple customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 4/24/25 |